Share Prices & Company Research

Stockbroking

Clinigen Group

Current Price 950.00p Bid 949.50p Ask 950.00p Change 0.05%
Last Updated: 19/07/2019 19:29. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Clinigen Group plc is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. The Group has sites in North America, Europe, Africa and Asia Pacific. In October 2018, the Group acquired CSM, a specialist provider of packaging, labelling, warehousing and distribution services, with sites in the US and Europe, and iQone, a specialist pharmaceutical company in Switzerland.

Financial Highlights Year Ended 30/06/2018

Turnover
£381.20m
Operating Profit
£41.50m
Dividend Yield
0.00
Dividend Per Share
5.60
Dividend Cover
3.96
P/E Ratio
41.46

Key Personnel

Shaun Edward Chilton
Chief Executive Officer
Nicholas Patrick Keher
Chief Financial Officer
Peter Vance Allen
Non-Executive Chairman
Prof Alan Keith Boyd
Non-Executive Director
Ian James Nicholson
Non-Executive Director
Anne Philomena Hyland
Non-Executive Director
John Hartup
Non-Executive Director

Stock Details

EPIC
CLIN
ISIN
GB00B89J2419
Shares in Issue
132,479,167
Market cap
£1,257.89m
Sector

Analyst Views (1)

Strong Buy
 
100.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
950.00p
Bid Price
949.50p
Ask Price
950.00p
Volume
216507
Change Today
0.50p
% Change Today
0.05%
Open
938.18p
Previous Close
950.00p
Intraday High
960.00p
Intraday Low
938.18p
52 Week High
1069.00p
52 Week Low
716.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Clinigen Group Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Tangible Assets
6.8
3.3
Intangible Assets & Goodwill
497.6
332.5
Investments & Other Non-Current Assets
9.2
12.3
Total Non-Current Assets
513.6
348.1
Inventory
21.3
16.7
Trade & Receivables
95.9
65.9
Cash & Receivables
36.3
27.8
Other Current Assets & Assets Held for Resale
0.0
1.0
Total Assets
667.1
459.5

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Short Term Liabilities
113.8
171.7
Long Term Liabilities
203.8
38.7
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
317.6
210.4

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Net Assets
349.5
249.1

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Share Capital
0.1
0.1
Minority Interests
0.0
0.0
Retained Earnings
94.9
71.6
Share Premium Account
161.3
161.2
Other Equity
93.2
16.2
Total Equity
349.5
249.1

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Cashflow from Operating Activities
47.6
46.1
Cashflow Before Financing
-75.6
37.3
Increase / Decrease in Cash
8.8
-0.5

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Turnover
381.2
302.3
Cost of Sales
242.5
179.6
Gross Profit
138.7
122.7
Operating Profit
41.5
44.8
Pre-Tax Profit
35.9
14.1
Profit / Loss for the Year
27.4
3.8

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H1 Dividend
21 Mar 2019
12 Apr 2019
H2 Dividend
08 Nov 2018
30 Nov 2018
H1 Dividend
22 Mar 2018
12 Apr 2018
H2 Dividend
09 Nov 2017
01 Dec 2017
H1 Dividend
23 Mar 2017
13 Apr 2017
H2 Dividend
03 Nov 2016
25 Nov 2016
H1 Dividend
17 Mar 2016
08 Apr 2016
H2 Dividend
15 Oct 2015
06 Nov 2015
H1 Dividend
12 Mar 2015
02 Apr 2015
H2 Dividend
16 Oct 2014
07 Nov 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.